MYD88 and diabetes mellitus: In a rat model of type 2 diabetes mellitus, TLR4/MyD88/NF-κB signaling led to the production of tumor necrosis factor-α, interleukin-6, and monocyte chemoattractant protein-1, which caused heart and liver complications (Tian et al., 2021).